
Boulder growth equity fund backing early-stage natural and organic products companies

Private investment firm providing growth capital to healthcare services, medical technology and health and wellness companies

Healthcare companies that already sell to customers receive expansion and growth capital from 1315 Capital. Its focus is on commercial-stage businesses in four areas: care delivery, medical technology, outsourcing for medtech and pharma, and health and wellness. The firm says it targets markets in which capable management teams can build businesses that improve patient care and the wider healthcare system.
The firm uses an operating team model. That team works through diligence and decisions with the goal of achieving premium exits. Alongside it, the investment team combines financial and business development skills with industry knowledge. The firm also draws on a broad network of executives, advisers, deal sources and board members, which it uses to find management talent and to test deals.
The portfolio includes a company that makes functional electrical stimulation equipment for patients recovering from neurological conditions. A forensic genomics business supplies next-generation sequencing equipment, solutions and software. An oncology diagnostics company gives oncologists and pathologists testing in hematology and solid tumor molecular profiling, and a bioinformatics business offers evidence-based molecular diagnostic tests and pathology services.
One portfolio company manufactures and distributes medical simulation and education products. Another provides AI-enabled decision support to life sciences sales and marketing teams. A multi-center services company provides transcranial magnetic stimulation to mental health patients, and a staffing and training company supplies outsourced support for extracorporeal membrane oxygenation and perfusion in hospitals.
Some holdings serve the industry from behind the scenes. A medical technology company applies hydrophilic coatings for device makers, a company reprocesses single-use medical devices, and a pre-clinical research organization provides drug discovery and early development assay services. A specialty clinical research organization focuses on metabolic diseases, including certain liver diseases, diabetes and obesity.
Consumer-facing businesses include a skin protection brand built on natural, mineral-based sun care and skin health products, and a nutrition technology company that helps users improve metabolic health through personalized data and dietitian support. A dermatology company develops prescription therapies for dermatologists, and a specialty pharmaceutical company focuses on nutraceutical and women's health products.
The site presents a set of companies under the heading of built-for-growth businesses. These include a premium skin health brand, a medical equipment liquidation and resale platform that specializes in auctions and facility liquidations, and an orthopedic oncology company that offers limb salvage implants and personalized 3D surgical planning. Its list also includes a preclinical research organization offering end-to-end drug discovery and early development assays.
1315 Capital is a private investment firm that puts expansion and growth capital into commercial-stage healthcare businesses. It looks for markets where strong management teams can scale platform companies quickly.
Companies in healthcare services, medical technology, medtech and pharma outsourcing, and health and wellness. Its portfolio ranges from neurological rehabilitation devices and forensic genomics to medical simulation, dermatology, oncology diagnostics and hospital cost-containment services.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about 1315 Capital.
Similar listings buyers compare against this one.

Boulder growth equity fund backing early-stage natural and organic products companies

Venture fund of Blue Cross Blue Shield plans investing in healthcare companies

Africa-focused investor that funds and mentors entrepreneurs, backed by the Chandaria Group of Companies

UK early-stage venture investor that uses a student network to assess technology and digital startups

Student-run early-stage venture fund at the University of Houston's Bauer College of Business

Seed and pre-seed venture firm run by former founders who back startups in any sector

Venture investor partnering with early-stage science and technology companies and venture funds

Software developer building cloud-based business applications with automated dashboards and reporting for growing companies
Everything here links back to the same verified catalogue. Pick your next stop.